KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Treasury Shares (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Treasury Shares data on record, last reported at $4.4 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 464.15% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $4.4 million, up 464.15%, while the annual FY2025 figure was $4.4 million, 464.15% up from the prior year.
  • Treasury Shares reached $4.4 million in Q4 2025 per JAZZ's latest filing, up from $781000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $4.4 million in Q4 2025 and bottomed at $338.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $1.5 million, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: plummeted 99.84% in 2022, then skyrocketed 621201.78% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $214000.0 in 2021, then tumbled by 99.84% to $338.0 in 2022, then surged by 621201.78% to $2.1 million in 2023, then crashed by 62.81% to $781000.0 in 2024, then surged by 464.15% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $4.4 million in Q4 2025, $781000.0 in Q4 2024, and $2.8 million in Q3 2024.